Robert W. Postma
Director · Alaunos Therapeutics, Inc.
IndividualBuying only
- 2025
- Oct 8, 2026
- 8
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Robert W. Postma. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jaime Vieser - $1K in TCRT purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert W. Postma?
Robert W. Postma is a corporate insider, tracked as Director of Alaunos Therapeutics, Inc. (TCRT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert W. Postma submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Robert W. Postma been buying or selling stock?
Recorded transactions: 3 open-market purchases ($5K) and 0 open-market sales across all tracked filings.
